Should You Invest In Hikma Pharmaceuticals PLC?

Get the facts about trading Hikma Pharmaceuticals PLC before you start. Discuss investment strategies, review market research, and get real-time updates

24,203 Hikma Pharmaceuticals PLC positions opened on eToro

Buy HIK.L
Sell HIK.L
HIK.LHikma Pharmaceuticals PLC
1638.7689.92 ( 5.81%)
AAPL
AAPLApple
141.82 (2.45%)
buy
GOOG
GOOGAlphabet
2371.82 (5.19%)
buy
META
METAMeta Platforms Inc
170.23 (7.19%)
buy
MSFT
MSFTMicrosoft
267.80 (3.41%)
buy
TWTR
TWTRTwitter
39.52 (1.89%)
buy

Hikma Pharmaceuticals plc was founded in 1978 and is based in London, England. The company develops, manufactures and markets quality branded and non-branded generic medicines. Hikma Pharmaceuticals operates the first US FDA inspected pharmaceutical manufacturing facility in the Middle East. The company has 29 manufacturing plants in 11 countries and 7 R&D centres. In 2017, Hikma Pharmaceuticals reported $1,936 million in revenue. Learn more about this instrument and buy HIK.L stocks.

Buy HIK.L Now
Sell HIK.L Now

Historical Price Charts

Discover the eToro Advantage

Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.

Volatility means opportunity! Watch price changes reflect directly onto your portfolio

Start trading within minutes - no physical purcase delays

Benefit from falling prices as well as rising prices. Buy or sell instantly

Zero commission is available to clients of eToro (Europe) Ltd., eToro (UK) Ltd. and eToro AUS Capital Limited (AFSL 491139).

Zero commission means that no broker fee will be charged when opening or closing the position. Other fees apply including FX fees on non-USD deposits and withdrawals. For additional information regarding fees, click here. Your capital is at risk.

eToro Service ARSN 637 489 466 operated by Gleneagle Asset Management ACN 103 162 278 AFSL 226199 and promoted by eToro AUS Capital Limited ACN 612 791 803 AFSL 491139. Investing in shares via a managed investment scheme does not result in direct ownership of the underlying assets. The scheme has legal ownership, the investor has beneficial ownership i.e. the shares are held on your behalf. As the scheme has legal ownership, you have no rights in the securities, including voting rights. Shares are non transferable. Your capital is at risk. Zero commission share trading is only available on limited stock exchanges. All other shares are offered as OTC Derivatives, and include commission. This information is general only and has been prepared without taking your objectives, financial situation or needs into account. You should obtain independent advice and consider our Product Disclosure Statement (PDS) before transacting.

eToro (Europe) Ltd., a Financial Services Company authorised and regulated by the Cyprus Securities Exchange Commission (CySEC) under the license # 109/10.

eToro (UK) Ltd, a Financial Services Company Authorised and regulated by the Financial Conduct Authority (FCA) under the license FRN 583263.

eToro (Seychelles) Ltd. is licenced by the Financial Services Authority Seychelles (“FSAS”) to provide broker-dealer services under the Securities Act 2007 License #SD076

Start Trading
Zero commission means that no broker fee will be charged when opening or closing the position and does not apply to short or leveraged positions. Other fees apply including FX fees on non-USD deposits and withdrawals. Your capital is at risk. For more information, click here.got it